Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sonnet Biotherapeutics Holdings Inc
(NQ:
SONN
)
0.7501
+0.0489 (+6.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sonnet Biotherapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via
Benzinga
Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast
October 25, 2023
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 150 points on Wednesday. The Dow traded up 0.20% to 33,206.51 while the NASDAQ fell 1.76% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
October 25, 2023
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 27.6% to $1.31 Wednesday morning after the company announced the pricing of a public offering involving 2,843,750 shares...
Via
Benzinga
EVGO Stock Slips as TD Cowen Downgrades EVgo
October 25, 2023
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.
Via
InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded down 0.26% to 33,053.68 while the NASDAQ fell 1.50% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via
Benzinga
Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today?
October 25, 2023
InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results.
Via
InvestorPlace
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
October 25, 2023
Sonnet BioTherapeutics stock is dropping on Wednesday after the company revealed the pricing of a public offering for SONN shares.
Via
InvestorPlace
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
October 25, 2023
Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million...
Via
Benzinga
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
October 25, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 25, 2023
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 24, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
October 17, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
September 20, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
September 19, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
Why Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated
August 31, 2023
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 24% to $0.21 Thursay afternoon after the company announced a 1-for-22 reverse stock split.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 01, 2023
On Friday, 57 companies reached new 52-week lows.
Via
Benzinga
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
August 31, 2023
Via
ACCESSWIRE
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 18, 2023
Via
Benzinga
Why Tower Semiconductor Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 16, 2023
Gainers
Via
Benzinga
What's Going On With Sonnet BioTherapeutics Stock Today?
August 16, 2023
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) shares are trading higher after the company announced that the IND for SB221, the Phase 1b/2a trial of SON-1010 (IL12-FHAB) in combination with Roche...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 16, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US
August 16, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
August 14, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.